Myocardial protection by Protykin, a novel extract of trans-resveratrol and emodin

References

• Renaud S., De Lorgeril M. Wine, alcohol, platelets and the French Paradox for coronary heart disease. Lancet 1993; 342: 1007–1011
   Google Scholar
• Hertog M.G.L., Feskens E.J.M., Kromhout D. Antioxidant flavonols and coronary heartdisease risk. Lancet 1997; 349: 699–699
   PubMed Web of Science ®Google Scholar
• Belch J.J.F., Bridges A.B., Scott N., Chopra M. Oxygen free radicals and congestive heart failure. British Heart Journal 1991; 65: 245–248
   PubMedGoogle Scholar
• Singal P.K., Kapur N., Dhillon K.S., Beamish R.E., Dhalla N.S. Role of free radicals in catecholamine-inducedcardiomopathy. Canadian Journal of Physiology and Pharmacology 1982; 60: 1390–1397
   PubMed Web of Science ®Google Scholar
• Otani H., Engelman R.M., Rousou J.A., Breyer R.H., Das D.K. Enhanced prostaglandin synthesis due to phospholipase breakdown in ischemic-reperfused myocardium. Control of its production by a phospholipase inhibitor or free radical scavengers. Journal of Molecular and Cellular Cardiology 1986a; 18: 953–961
   PubMed Web of Science ®Google Scholar
• Otani H., Engelman R.M., Rousou J.A., Breyer R.H., Lemeshow S., Das D.K. Cardiac performance during reperfusion improved by pretreatment with oxygen free radical scavengers. Journal of Thoracic and Cardiovascular Surgery 1986b; 91: 290–295
   PubMed Web of Science ®Google Scholar
• Steinbrecher U.P., Zhang H., Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radical Biology and Medicine 1990; 9: 155–168
   PubMed Web of Science ®Google Scholar
• Das D.K., Maulik N. Protection against free radical injury in the heart and cardiac performance. Exercise and Oxygen Toxicity, C.K. Sen, L. Packer, O. Hanninen. Elsevier Science, Amsterdam 1995, In
   Google Scholar
• Gay K.F., Puska P., Jordan P., Moser U.K. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. American Journal of Clinical Nutrition 1991; 53: 3265–3345
   Google Scholar
• Gay K.F. On the antioxidant hypothesis with regard to arteriosclerosis. Bibl Nutrition Dieta 1986; 37: 53–91
   Google Scholar
• Engelman D., Watanabe M., Engelman R.M., Rousou J.A., Kisin E., Kagan V.E., Maulik N., Das D.K. Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovascular Research 1995; 29: 133–140
   Google Scholar
• Yoshida T., Watanabe M., Engelman D.T., Engelman R.M., Schley J.A., Maulik N., Ho Y.-S., Oberley T.D., Das D.K. Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury. Journal of Molecular and Cellular Cardiology 1996; 28: 1759–1767
   Google Scholar
• Cordis G.A., Maulik N., Das D.K. Detection of oxidative stress in heart by estimating the dinitrophenyl-hydrazine derivative of malonaldehyde. Journal of Molecular and Cellular Cardiology 1995; 27: 1645–1653
   PubMed Web of Science ®Google Scholar
• Makrigiorgos G.M., Kassis A., Mahmood A., Bump E., Savvides P. Novel fluorescein-based flow cytometric method for detection of lipid peroxidation. Free Radical Biology and Medicine 1997; 22: 93–100
   PubMed Web of Science ®Google Scholar
• Collins A.K., Makrigiorgos G.M., Svensson G.K. Coumarin chemical dosimeter for radiation therapy. Medical Physics 1994; 21: 1741–1747
   PubMed Web of Science ®Google Scholar
• Cordis G.A., Maulik G., Bagchi D., Riedel W., Das D.K. Detection of oxidative DNA damage to ischemic reperfused rat hearts by 8-hydroxydeoxyguanosine formation. Journal of Molecular and Cellular Cardiology 1998; 30: 1939–1944
   PubMedGoogle Scholar
• Das D.K., Maulik N. Evaluation of antioxidant effectiveness in ischemia reperfusion tissue injury methods. Methods in Enzymology 1994; 233: 601–610
   PubMed Web of Science ®Google Scholar
• Arroyo C.M., Kramer J.H., Dickens B.F., Weglicki W.B. Identification of free radicals in myocardial ischemia/reperfusion by spin trapping with nitrone DMPO. FEBS Letter 1987; 221: 101–104
   PubMed Web of Science ®Google Scholar
• Maulik N., Watanabe M., Engelman D., Engelman R.M., Kagan V.E., Kisin E., Tyurin V., Cordis G.A., Das D.K. Myocardial adaptation to ischemia by oxidative stress induced by endotoxin. American Journal of Physiology 1995; 269: C907–C916
   Google Scholar
• Tosaki A., Bagchi D., Hellegouarch T., Pali T., Cordis G.A., Das D.K. Comparisons of ESR and HPLC methods for the detection of hydroxyl radicals in ischemic/reperfused hearts. A relationship between the genesis of oxygen-free radicals and reperfusion-induced arrhythmias. Biochemical Pharmacology 1993; 45: 961–969
   PubMed Web of Science ®Google Scholar
• Roots R., Okada S. Estimation of life times and diffusion distances of radicals involved in X-ray induced DNA strand breaks or killing of mammalian cells. Radiation Research 1975; 64: 306–320
   PubMed Web of Science ®Google Scholar
• Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiological Review 1979; 59: 527–540
   PubMed Web of Science ®Google Scholar
• Frei B., Stocker R., Ames B.N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proceedings of National Academy of Sciences (USA) 1988; 85: 9748–9751
   PubMed Web of Science ®Google Scholar
• Stocker R., Peterhans E. Synergistic interaction between vitamin E and the bile pigments bilirubin and biliverdin. Biochimica Biophysica Acta 1989; 1002: 238–243
   PubMedGoogle Scholar
• New York, Marcel Dekker, D.J. Hearse, A.J. Roberts, 1987; 7–17
   Google Scholar
• Das D.K., Engelman R.M., Rousou J.A., Breyer R.H., Otani H., Lemeshow S. Pathophysiology of superoxide radical as potential mediator of ischemic and reperfusion injury in pig heart. Basic Research in Cardiology 1986; 81: 155–166
   PubMed Web of Science ®Google Scholar
• Zhang L., Bacus S.S., Chang C.J., Hung M.C. Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. Cancer Research 1995; 55: 3890–3896
   PubMedGoogle Scholar
• Uenobe F., Miyazawa M., Nakamura S. Antimutagenic effect of resveratrol against Trp-1. Mutation Research 1997; 373: 197–199
   Google Scholar
• Soleas G.J., Diamandis E.P., Goldberg D.M. Wine as a biological fluid: history, production and role in disease prevention. Journal of Clinical Laboratory Analysis 1997; 11: 287–313
   PubMed Web of Science ®Google Scholar
• Jang M., Cai L., Udeani G.O. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275: 218–220
   PubMed Web of Science ®Google Scholar
• Sun A.Y., Chen Y.M., James-Kracke M. Ethanol-induced cell death by lipid peroxidation in PC12 cells. Neurochemical Research 1997; 22: 1187–1192
   PubMed Web of Science ®Google Scholar
• Chen C.K., Pace-Asciak C.R. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. General Pharmacology 1996; 27: 363–366
   PubMedGoogle Scholar
• Huang H.S., Chu S.H., Lee P.D. Vasorelaxants from chinese herbs, emodin and scoparone, possess immunosuppressive properties. Eurorean Journal of Pharmacology 1991; 198: 211–216
   PubMed Web of Science ®Google Scholar
• Liberman D.F., Fink R.C., Shaofers F.L., Mulchay R.J., Stark A.A. Mutagenicity of anthroquinone and hydroxylated anthroquinones in the Ames/Salmonella microsome syste. Applied Environmental Microbiology 1993; 43: 1354–1359
   Google Scholar
• Kuo Y.-C., Sun C.-M., Ou J.-C., Tsai W.-J. A tumor cell growth inhibitor from Polygonum hypolecum ohwai. Life Sciences 1997; 61: 2335–2344
   PubMedGoogle Scholar
• Teng C.M., Lin C.H., Lin C.N., Chung M.I., Huang T.F. Frangulin B, an antagonist of collagen-induced platelet aggregation and adhesion, isolated from Rhamus formosana. Thrombosis Haemostasis 1993; 70: 1014–1018
   Google Scholar
• Gaziano J.M., Buring J.E., Breslow J.L., Goldhaber S.Z., Rosner B., VanDenburgh M., Willett W., Henekens C.H. Moderate alcohol intake, increased levels of high-density lipoprotein and its sub-fractions and decreased risk of myocardial infarction. New England Journal of Medicine 1993; 329: 1829–1834
   PubMed Web of Science ®Google Scholar
• Frankel E.N., Kanner J., German J.B. Inhibition of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993; 341: 454–457
   PubMed Web of Science ®Google Scholar
• Ridker P.M., Vaughan D.E., Stampfer M.J., Glynn R.J., Hennekens C.H. Association of moderate alcohol consumption and plasma concentration of tissue-type plasminogen activator. Journal of American Medical Association 1994; 272: 929–933
   PubMed Web of Science ®Google Scholar
• Mikhailidis D.P., Jeremy J.Y., Barradas M.A., Green N., Dandona P. Effect of ethanol on vascular prostacyclin synthesis, platelet aggregation and platelet thromboxane release. British Medical Journal 1993; 87: 1495–1498
   Google Scholar
• Demrow H., Slane P., Folts J. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 1995; 91: 1182–1188
   PubMed Web of Science ®Google Scholar
• Saija A., Marzullo D., Scalese M., Bonina F., Laiza M., Castelli F. Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radical Biology and Medicine 1995; 19: 481–486
   PubMed Web of Science ®Google Scholar
• Rice-Evans C., Miller N.J., Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biology and Medicine 1996; 20: 933–956
   PubMed Web of Science ®Google Scholar